Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Arterial Hypertension

Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.

483 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension trial results

Recruiting

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

NCT07318597

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +5 more
Locations
  • University of Colorado Denver Aurora, Colorado, United States
  • Mater Misericordiae Ltd South Brisbane, Queensland, Australia
  • Royal Hobart Hospital Hobart, Tasmania, Australia
  • UZ Leuven Leuven, Vlaams-Brabant, Belgium
View all 32 locations
View Trial Details
Recruiting

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

NCT05179876

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • The Republican Scientific-Practical Center ''Cardiology'' Minsk, Belarus
  • Minsk Regional Clinical Hospital Of The Red Banner Of Labor Minsk, Belarus
  • UZ Leuven Leuven, Belgium
  • University Multiprofile Hospital for Active Treatment- UMHAT Sveta Anna AD Sofia, Bulgaria
View all 45 locations
View Trial Details
Recruiting

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT07218029

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Pulmonary Associates, PA ( Site 1008) Phoenix, Arizona, United States
  • University of California San Diego Health ( Site 1002) La Jolla, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights ( Site 1019) San Francisco, California, United States
  • Jeffrey S. Sager, MD Medical Corporation ( Site 1060) Santa Barbara, California, United States
View all 137 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

NCT07481981

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • USA008 Santa Barbara, California, United States
  • USA007 Anderson, South Carolina, United States
  • JPN003 Okayama, Okayama-ken, Japan
  • USA012 Los Angeles, California, United States
View all 26 locations
View Trial Details

Related conditions